Breaking News: ENDP latest news.

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Paulson adds Kirkland Lake, exits Caesars in Q1 » 16:37 05/15/20 05/15 16:37 05/15/20 16:37 KL Kirkland Lake Gold $41.02 / +0.91 (+2.27%) , NAV Navistar $23.41 / +0.77 (+3.40%) , AEM Agnico Eagle $68.96 / +2.88 (+4.36%) , CZR Caesars $10.05 / +0.185 (+1.88%) , LOGM LogMeln $85.29 / +0.23 (+0.27%) , TIF Tiffany $127.06 / -0.08 (-0.06%) , TECD Tech Data $137.03 / +0.03 (+0.02%) , QEP QEP Resources $0.74 / +0.0452 (+6.52%) , ENDP Endo $3.81 / -0.035 (-0.91%) , NG NovaGold $11.71 / +0.27 (+2.36%) , GLD SPDR Gold Shares $163.95 / +0.96 (+0.59%) , DISCA Discovery $20.48 / -0.07 (-0.34%) , AU AngloGold $27.75 / +1.71 (+6.57%) , TSU Tim Participacoes $10.48 / -0.38 (-3.50%) , PCG PG&E $11.35 / +0.245 (+2.21%) , BHC Bausch Health $15.74 / -0.2 (-1.25%) , HZNP Horizon Therapeutics $47.07 / +2.35 (+5.25%) , TAK Takeda Pharmaceutical $18.60 / -0.07 (-0.38%) John Paulson's… John Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of March 31, 2020. The fund's two new buys during the first quarter included, by size of position, Kirkland Lake (KL) and Navistar (NAV). Paulson exited six holdings during the quarter, including by size of previous position Agnico Eagle Mines (AEM), Caesars (CZR), and LogMeIn (LOGM). The fund increased its stake in five holdings, including by size of previous position Tiffany (TIF), Tech Data (TECD), QEP Resources (QEP), Endo (ENDP), and Novagold (NG). Paulson reduced its stake in nine holdings, including by size of previous position SPDR Gold Shares (GLD), Discovery (DISCA), AngloGold Ashanti (AU), Tim Participacoes (TSU), and Pretium Resources (PVG). The fund's top holdings as of March 31, in order of size, were Bausch Health (BHC), SPDR Gold Shares, Horizon Therapeutics (HZNP), Takeda Pharmaceutical (TAK), and AngloGold Ashanti. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options Technical Analysis TIF TECD TAK QEP PCG NG NAV LOGM KL HZNP GLD ENDP DISCA CZR BHC AU AEM TIF Tiffany $127.06 / -0.08 (-0.06%) 03/23/20 LVMH says will not buy Tiffany shares on open market 03/20/20 Tiffany reports Q4 SSS ex-Hong Kong market up 5% 03/20/20 Tiffany reports net inventories at January 31 'largely unchanged' y/y 03/20/20 Tiffany says not providing FY guidance due to pending merger with LVMH TECD Tech Data $137.03 / +0.03 (+0.02%) 03/24/20 Tech Data disagrees and will appeal findings of French Competition Authority 02/19/20 Tech Data expands AWS cloud support capabilities with nOps partnership 02/14/20 Paulson adds Pretium, exits United Tech in Q4 02/10/20 Inflow Technologies withdraws from acquisition by Tech Data TAK Takeda Pharmaceutical $18.60 / -0.07 (-0.38%) 05/14/20 Takeda Pharmaceutical receives EC approval for Adcetris MA extension 05/11/20 Protalix: BRIDGE study successfully met main safety, efficacy objectives 04/23/20 Takeda Pharmaceutical, ProThera Biologics enter global licensing agreement 04/06/20 Takeda Pharmaceutical, others collaborate on COVID-19 hyperimmune therapy QEP QEP Resources $0.74 / +0.0452 (+6.52%) 04/29/20 QEP Resources decreases FY20 CapEx projections 04/16/20 QEP Resources gets NYSE continued listing notice, may pursue stock split 03/13/20 QEP Resources plans to suspend 2c dividend following March 20 payment 03/13/20 QEP Resources expects to reduce planned 2020/2021 capex by over $300M PCG PG&E $11.35 / +0.245 (+2.21%) 05/15/20 PG&E rallies 2% to $11.34 after judge refuses to toss out victim bankruptcy vote 05/08/20 CPUC penalizes PG&E $1.94B for 2017 and 2018 wildfires 05/04/20 PG&E rises 5.5% NG NovaGold $11.71 / +0.27 (+2.36%) 03/23/20 NovaGold says has sufficient funds to advance Donlin Gold 02/06/20 NovaGold receives State of Alaska approvals for Donlin Gold project NAV Navistar $23.41 / +0.77 (+3.40%) 05/06/20 Navistar says City of Tulsa threatening to evict IC Bus from Airport facility 04/24/20 EU commercial vehicle registrations down 47.3% in March, down 23.2% in Q1 04/13/20 Navistar postpones 30% of planned capex, defers up to 30% pay for certain staff 04/02/20 Navistar says Springfield truck plant output to resume April 27 LOGM LogMeln $85.29 / +0.23 (+0.27%) 05/06/20 LogMeln announces new edition of GoToMeeting 04/30/20 HTC debuts remote collaboration, meeting platform for VR VIVE Sync 04/23/20 LogMeln confirms status of merger agreement 04/15/20 LogMeln announces new contact center for CCaaS KL Kirkland Lake Gold $41.02 / +0.91 (+2.27%) 04/08/20 Kirkland Lake Gold reports Q1 production up 43% y-o-y to 330,864 oz, 03/29/20 Kirkland Lake Gold says worker at Detour Lake Mine tested positive for COVID-19 03/23/20 Kirkland Lake suspends all non-essential work, exploration activities 03/18/20 Kirkland Lake Gold doubles dividend to 12.5c per share HZNP Horizon Therapeutics $47.07 / +2.35 (+5.25%) 05/06/20 Horizon Therapeutics announces two new Tepezza pipeline programs 04/27/20 Horizon Therapeutics announces availability of PROCYSBI granules in U.S. 04/02/20 Horizon Therapeutics acquires Curzion Pharmaceuticals 03/31/20 Horizon Therapeutics says Tepezza reduced proptosis regardless of age GLD SPDR Gold Shares $163.95 / +0.96 (+0.59%) 05/14/20 SPDR Gold Shares holdings rise to 1,104.72MT from 1,092.14MT 05/13/20 SPDR Gold Shares holdings rise to 1,092.14MT from 1,083.66MT 05/12/20 SPDR Gold Shares holdings rise to 1,083.66MT from 1,081.07MT 05/06/20 SPDR Gold Shares holdings fall to 1,075.80MT from 1,076.39MT ENDP Endo $3.81 / -0.035 (-0.91%) 05/07/20 Endo up 6% after reporting Q1 results 05/07/20 Endo reports Q1 International Pharmaceuticals segment revenue $29M 05/07/20 Endo reports Q1 Generic Pharmaceuticals revenue $251M vs. $219M last year 05/07/20 Endo reports Q1 Sterile Injectables segment revenue $336M vs. $270M last year DISCA Discovery $20.48 / -0.07 (-0.34%) 05/06/20 Discovery: April ad sales down 20%, May and June look 'slightly better' 05/06/20 Discovery: Unscripted TV 'the new sports" during coronavirus pandemic 05/06/20 Discovery sees core costs down mid to high single digits 05/06/20 Discovery: International ad sales down 40% in April CZR Caesars $10.05 / +0.185 (+1.88%) 05/15/20 Appaloosa buys Twitter, Netflix stakes, exits Caesars, cuts Facebook position 05/14/20 New Jersey reports April gaming revenue down 68.9% y/y to $82.6M 05/11/20 Caesars says Louisiana casinos could open this coming weekend 05/11/20 Caesars says will open 3 or 4 Vegas casinos when allowed BHC Bausch Health $15.74 / -0.2 (-1.25%) 05/06/20 Bausch Health, Alfasigma announce resolution of XIFAXAN IP litigation 04/29/20 Bausch Health: FDA Approves Ortho Dermatologics' labeling for JUBLIA 04/28/20 Clearside, Bausch Health amend partnership for XIPERE 04/28/20 Clearside Biomedical revises NDA resubmission timeline for XIPERE AU AngloGold $27.75 / +1.71 (+6.57%) 02/20/20 Barrick Gold says will not approve sale of Sokimo's stake in Kibali 02/12/20 AngloGold sells South African assets to Harmony amid priorities shift 12/23/19 IAMGold, AngloGold Ashanti to sell stake in Mali mine for $105M AEM Agnico Eagle $68.96 / +2.88 (+4.36%) 04/14/20 Agnico Eagle takes steps to resume operations in the Abitibi region 04/14/20 Yamana Gold says Canadian Malartic mine will resume operations April 15 04/02/20 Agnico Eagle provides update on Finland and Nunavut operations 04/02/20 Agnico Eagle ramping down Mexico operations until April 30 KL NAV AEM CZR LOGM TIF TECD QEP ENDP NG GLD DISCA AU TSU PCG BHC HZNP TAK KL Kirkland Lake Gold $41.02 / +0.91 (+2.27%) 04/07/20 BofA Kirkland Lake Gold initiated with a Buy at BofA 04/02/20 RBC Capital RBC Capital maintains Outperform on Kirkland Lake Gold 03/24/20 Canaccord Kirkland Lake Gold upgraded to Buy from Hold at Canaccord 03/18/20 CIBC Kirkland Lake Gold upgraded to Outperformer from Neutral at CIBC NAV Navistar $23.41 / +0.77 (+3.40%) 05/07/20 Longbow Navistar likely to beat near-term expectations, says Longbow 04/17/20 JPMorgan Truck cancellation rate in March hits high at 43%, says JPMorgan 04/03/20 JPMorgan Class 8 truck orders dropped 51% in March, says JPMorgan 03/17/20 Baird Baird says 'great opportunity' to get back involved with Navistar AEM Agnico Eagle $68.96 / +2.88 (+4.36%) 05/01/20 TD Securities Agnico Eagle price target lowered to C$76 from C$77 at TD Securities 05/01/20 BMO Capital Agnico Eagle price target raised to C$60 from C$54 at BMO Capital 05/01/20 CIBC CIBC backs Outperformer on Agnico Eagle after 'solid' Q1 results 05/01/20 RBC Capital Agnico Eagle's Q1 results mixed relative to expectations, says RBC Capital CZR Caesars $10.05 / +0.185 (+1.88%) 05/12/20 Deutsche Bank Caesars price target lowered to $11 from $13 at Deutsche Bank 05/12/20 Jefferies Eldorado Resorts price target raised to $38 from $29 at Jefferies 04/17/20 SunTrust Caesars, Twin River Worldwide upgraded to Buy from Hold at SunTrust 04/17/20 SunTrust Caesars upgraded to Buy from Hold at SunTrust LOGM LogMeln $85.29 / +0.23 (+0.27%) 01/15/20 Piper Sandler Piper introduces long VMware, short Juniper pair trade into Q4 results 01/03/20 Fly Intel: Top five analyst downgrades 01/03/20 LogMeln downgraded to Sector Weight from Overweight at KeyBanc 01/02/20 KeyBanc LogMeln downgraded to Sector Weight from Overweight at KeyBanc TIF Tiffany $127.06 / -0.08 (-0.06%) 12/09/19 Cowen Tiffany downgraded to Market Perform from Outperform at Cowen 12/06/19 Fly Intel: Top five analyst downgrades 12/06/19 Loop Capital Tiffany price target raised to $135 from $85 at Loop Capital 12/06/19 Credit Suisse Tiffany's best path forward likely the LVMH deal, says Credit Suisse TECD Tech Data $137.03 / +0.03 (+0.02%) 03/18/20 Northcoast Tech Data upgraded to Buy from Neutral at Northcoast 12/10/19 Northcoast Tech Data downgraded to Neutral from Buy at Northcoast 10/17/19 Loop Capital Tech Data price target raised to $150 from $130 at Loop Capital 10/16/19 Stifel Tech Data investors likely to want higher takeout price, says Stifel QEP QEP Resources $0.74 / +0.0452 (+6.52%) 04/07/20 Scotiabank QEP Resources downgraded to Underperform from Sector Perform at Scotiabank 03/31/20 Piper Sandler QEP Resources downgraded to Underweight from Neutral at Piper Sandler 03/20/20 Stephens Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down 03/20/20 Stephens QEP Resources downgraded to Equal Weight from Overweight at Stephens ENDP Endo $3.81 / -0.035 (-0.91%) 04/24/20 Fly Intel: Top five analyst initiations 04/24/20 Citi Endo initiated with a Buy at Citi 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim NG NovaGold $11.71 / +0.27 (+2.36%) GLD SPDR Gold Shares $163.95 / +0.96 (+0.59%) DISCA Discovery $20.48 / -0.07 (-0.34%) 05/14/20 Barrington Discovery price target lowered to $28 from $34 at Barrington 04/27/20 RBC Capital Discovery initiated with an Outperform at RBC Capital 04/23/20 Evercore ISI Discovery downgraded to In Line from Outperform at Evercore ISI 04/17/20 Citi Discovery price target lowered to $27 from $39 at Citi AU AngloGold $27.75 / +1.71 (+6.57%) 04/21/20 BofA AngloGold upgraded to Neutral from Underperform at BofA 02/06/20 UBS AngloGold initiated with a Neutral at UBS 10/18/19 Goldman Sachs AngloGold upgraded to Buy from Neutral at Goldman Sachs 06/27/19 BMO Capital AngloGold upgraded to Outperform from Market Perform at BMO Capital TSU Tim Participacoes $10.48 / -0.38 (-3.50%) 04/21/20 HSBC Tim Participacoes upgraded to Hold from Reduce at HSBC 01/24/20 HSBC Tim Participacoes downgraded to Reduce from Hold at HSBC 08/01/19 Barclays Barclays upgrades Tim Participacoes to Overweight, downgrades Telefonica Brasil 08/01/19 Barclays Tim Participacoes upgraded to Overweight from Equal Weight at Barclays PCG PG&E $11.35 / +0.245 (+2.21%) 05/15/20 Barclays Barclays upgrades Utilities sector along with PG&E and two others 05/15/20 Barclays PG&E upgraded to Overweight from Equal Weight at Barclays 05/06/20 Mizuho PG&E price target raised to $13.50 from $12.50 at Mizuho 05/04/20 Fly Intel: Top five analyst upgrades BHC Bausch Health $15.74 / -0.2 (-1.25%) 04/24/20 Citi Bausch Health initiated with a Buy at Citi 04/02/20 Morgan Stanley Bausch Health downgraded to Equal Weight with $17 price target at Morgan Stanley 04/02/20 Morgan Stanley Bausch Health downgraded to Equal Weight from Overweight at Morgan Stanley HZNP Horizon Therapeutics $47.07 / +2.35 (+5.25%) 05/08/20 Morgan Stanley Horizon Therapeutics price target raised to $50 from $39 at Morgan Stanley 04/14/20 Piper Sandler Horizon Therapeutics risk/reward profile 'highly attractive,' says Piper Sandler 02/21/20 Cantor Fitzgerald Selecta positioned for 50%-100% rally on positive data, says Cantor Fitzgerald 01/22/20 BMO Capital Horizon Therapeutics price target raised to $46 from $40 at BMO Capita TAK Takeda Pharmaceutical $18.60 / -0.07 (-0.38%) 04/20/20 SVB Leerink Ascendis Pharma price target raised to $170 from $152 at SVB Leerink 03/25/20 Piper Sandler Piper Sandler backs Overweight on 'well capitalized' Exelixis 03/25/20 Stifel Molecular Templates initiated with a Buy at Stifel 02/25/20 Stifel Iovance among 'more interesting' cell therapy takeout candidates, says Stifel TIF TECD TAK QEP PCG NAV LOGM KL HZNP ENDP DISCA CZR BHC AEM TIF Tiffany $127.06 / -0.08 (-0.06%) 03/20/20 Tiffany reports Q4 adjusted EPS $1.80, consensus $1.77 12/05/19 Tiffany reports Q3 EPS 65c, consensus 85c 12/04/19 Notable companies reporting before tomorrow's open TECD Tech Data $137.03 / +0.03 (+0.02%) 03/05/20 Tech Data reports Q4 adjusted EPS $4.88, consensus $4.82 11/26/19 Tech Data reports Q3 adjusted EPS $3.02, consensus $2.99 TAK Takeda Pharmaceutical $18.60 / -0.07 (-0.38%) 01/07/20 Kamada sees FY20 revenue $132M-$137M, consensus $121.51M QEP QEP Resources $0.74 / +0.0452 (+6.52%) 04/29/20 QEP Resources reports Q1 EPS 21c, consensus 0c 03/13/20 QEP Resources says 2020 guidance 'should no longer be relied upon' 02/26/20 QEP Resources reports Q4 adj. EPS (10c), consensus 8c PCG PG&E $11.35 / +0.245 (+2.21%) 05/01/20 PG&E not providing FY20 guidance 05/01/20 PG&E reports Q1 core EPS 89c, consensus $1.02 02/18/20 PG&E reports Q4 adj. EPS 68, consensus 67c NAV Navistar $23.41 / +0.77 (+3.40%) 03/23/20 Navistar withdraws FY20 guidance, suspends production in Ohio assembly plant 03/04/20 Navistar backs FY20 revenue view $9.25B-$9.75B, consensus $9.44B 03/04/20 Navistar reports Q1 EPS (36c), consensus (19c) 12/17/19 Navistar cuts FY20 revenue view to $9.25B-$9.75B from $10B-$10.5B LOGM LogMeln $85.29 / +0.23 (+0.27%) 04/23/20 LogMeln reports Q1 EPS 1.21, consensus $1.19 02/13/20 LogMeln reports Q4 EPS $1.43, consensus $1.40 KL Kirkland Lake Gold $41.02 / +0.91 (+2.27%) 04/02/20 Kirkland Lake Gold withdraws FY20 guidance HZNP Horizon Therapeutics $47.07 / +2.35 (+5.25%) 05/06/20 Horizon Therapeutics widens FY20 revenue view to $1.4B-$1.45B from $1.4B-$1.42B 05/06/20 Horizon Therapeutics reports Q1 EPS 40c, consensus 22c 02/26/20 Horizon Therapeutics sees FY20 revenue view $1.4B-$1.42B, consensus $1.39B 02/26/20 Horizon Therapeutics reports Q4 adj. EPS 56c, consensus 42c ENDP Endo $3.81 / -0.035 (-0.91%) 05/07/20 Endo reports Q1 adj. EPS 94c, consensus 54c 02/26/20 Endo sees FY20 adj. EPS $2.15-$2.40, consensus $2.25 02/26/20 Endo reports Q4 EPS 74c, consensus 57c DISCA Discovery $20.48 / -0.07 (-0.34%) 05/06/20 Discovery reports Q1 adjusted EPS 87c, consensus 84c 05/05/20 Notable companies reporting before tomorrow's open 03/25/20 Discovery withdraws FY20 outlook due to COVID-19 pandemic CZR Caesars $10.05 / +0.185 (+1.88%) 05/11/20 Caesars reports Q1 EPS (36c), consensus (18c) 05/11/20 Notable companies reporting after market close 02/25/20 Caesars reports Q4 EPS (45c), may not compare to consensus (11c) 02/25/20 Notable companies reporting after market close BHC Bausch Health $15.74 / -0.2 (-1.25%) 05/07/20 Bausch Health lowers three-year CAGR targets due to pandemic 05/07/20 Bausch Health lowers FY20 revenue view to $7.8B-$8.2B from $8.65B-$8.85B 05/07/20 Bausch Health reports Q1 GAAP EPS (43c), does not compare to consensus 89c AEM Agnico Eagle $68.96 / +2.88 (+4.36%) 04/30/20 Agnico Eagle reports Q1 EPS 23c, consensus 18c 02/13/20 Agnico Eagle reports Q4 adj. EPS 37c, consensus 38c TIF TECD TAK PCG NAV LOGM KL ENDP DISCA CZR TIF Tiffany $127.06 / -0.08 (-0.06%) 03/19/20 LVMH said considering buying Tiffany on open market, Bloomberg says 03/17/20 Tiffany temporarily shutters several stores amid COVID-19 concerns, Reuters says 02/08/20 Sustainable companies in America beating the market, Barron's says 01/02/20 Warren Buffett rejected Tiffany's advances amid LVMH deal, FT reports TECD Tech Data $137.03 / +0.03 (+0.02%) 04/02/20 Tech Data buyer Apollo still on track to close deal, Dealreporter says 03/17/20 Dealreporter thinks Tech Data could have buyer waiting if Apollo deal breaks 03/16/20 Apple, Tech Data sanctioned in France, Autorite de la Concurrence reports 11/29/19 Berkshire Hathaway bid for Tech Data before deal struck with Apollo, CNBC says TAK Takeda Pharmaceutical $18.60 / -0.07 (-0.38%) 04/23/20 Two drugs studied in Bay Area may lessen COVID-19 deaths, SF Chronicles says 04/12/20 J&J abandons deal for Takeda's TachoSil surgical patch, Reuters reports 03/25/20 EU to investigate JNJ deal to purchase Takeda surgical patch, Reuters reports PCG PG&E $11.35 / +0.245 (+2.21%) 05/15/20 PG&E judge to deny motions asking to throw out votes, Bloomberg reports 05/15/20 PG&E judge to deny motions askaing to throw out votes, Bloomberg reports 05/15/20 PG&E judge rejects bid to toss out fire victims bankruptcy vote, Bloomberg says 04/30/20 PG&E faces formal vote in $13.5B wildfire settlement, NYT reports NAV Navistar $23.41 / +0.77 (+3.40%) 03/17/20 VW says still wants to acquire Navistar, but needs to save cash, Reuters reports 01/30/20 Volkswagen said to plan offer to buy rest of Navistar, Bloomberg reports 12/31/19 Heavy-truck market settles down amid technology advance, Equipment World says 12/04/19 Whistle-blower accuses Navistar of overcharging U.S. government, Bloomberg says LOGM LogMeln $85.29 / +0.23 (+0.27%) 12/11/19 PE firms in talks to buy LogMeln, Bloomberg says 12/11/19 PE firms in talks to buy LogMeln, Bloomberg says KL Kirkland Lake Gold $41.02 / +0.91 (+2.27%) 03/24/20 Goldman tells clients to buy gold, Financial Times says ENDP Endo $3.81 / -0.035 (-0.91%) 02/25/20 Endo beats generic-delay claim brought by Fresenius, Bloomberg says DISCA Discovery $20.48 / -0.07 (-0.34%) 03/24/20 Japan Prime Minister says Olympics to be postponed until 2021, Variety reports 03/24/20 Comcast assuming Tokyo Olympics will be postponed, WSJ reports 03/23/20 IOC member says 2020 Olympics will be postponed, USA Today reports 02/01/20 Oracle, Discovery still looking cheap, Barron's says CZR Caesars $10.05 / +0.185 (+1.88%) 05/07/20 Nevada Gaming Commission approves casino virus safety measures, Bloomberg says 03/31/20 Eldorado Resorts deal with Caesars only delayed, CNBC reports 03/31/20 Eldorado Resorts deal with Caesars moving forward, CNBC says 03/30/20 Eldorado's deal to buy Caesars could be in danger, NY Post reports TIF TECD QEP PCG NAV LOGM KL ENDP DISCA CZR BHC TIF Tiffany $127.06 / -0.08 (-0.06%) 01/06/20 Citron reiterates RH as top long, Peloton as top short idea for 2020 01/02/20 Fly Intel: Wall Street's top stories for Thursday 01/02/20 Fly Intel: Wall Street's top stories at midday TECD Tech Data $137.03 / +0.03 (+0.02%) 11/29/19 Fly Intel: Wall Street's top stories for Friday QEP QEP Resources $0.74 / +0.0452 (+6.52%) 03/09/20 Oil-linked stocks see mass of downgrades on potential 'Energy Armageddon' PCG PG&E $11.35 / +0.245 (+2.21%) 05/04/20 Fly Intel: Pre-market Movers 03/23/20 Fly Intel: Pre-market Movers 03/17/20 Fly Intel: Pre-market Movers 02/03/20 Fly Intel: Wall Street's top stories for Monday NAV Navistar $23.41 / +0.77 (+3.40%) 01/31/20 Fly Intel: Wall Street's top stories for Friday 01/31/20 Fly Intel: Wall Street's top stories at midday LOGM LogMeln $85.29 / +0.23 (+0.27%) 12/17/19 Fly Intel: Wall Street's top stories for Tuesday 12/17/19 Fly Intel: Wall Street's top stories at midday 12/11/19 Fly Intel: Wall Street's top stories for Wednesday 12/11/19 Fly Intel: Wall Street's top stories at midday KL Kirkland Lake Gold $41.02 / +0.91 (+2.27%) 11/25/19 Fly Intel: Wall Street's top stories for Monday 11/25/19 Fly Intel: Wall Street's top stories at midday ENDP Endo $3.81 / -0.035 (-0.91%) 02/24/20 Fly Intel: Wall Street's top stories for Monday 02/24/20 Opioid-linked names follow Mallinckrodt lower as unit bankruptcy said possible DISCA Discovery $20.48 / -0.07 (-0.34%) 03/24/20 Comcast slips after warning on 'adverse impact' from COVID-19, Olympics pushout CZR Caesars $10.05 / +0.185 (+1.88%) 05/11/20 Fly Intel: After-Hours Movers 03/31/20 Fly Intel: Wall Street's top stories for Tuesday 03/18/20 Fly Intel: Wall Street's top stories for Wednesday 03/18/20 Fly Intel: Wall Street's top stories at midday BHC Bausch Health $15.74 / -0.2 (-1.25%) 05/07/20 Fly Intel: Wall Street's top stories for Thursday 05/07/20 Fly Intel: Wall Street's top stories at midday 01/22/20 Boeing downgrade, Bausch upgrade among today's top analyst calls 07/06/20 PDUFA Date for CCH 06/01/20 Tiffany & Co. 06/11/20 LogMeIn, Inc. TIF TAK PCG NG LOGM KL GLD ENDP DISCA CZR BHC AEM TIF Tiffany $127.06 / -0.08 (-0.06%) 05/01/20 Tiffany call volume above normal and directionally bullish 04/22/20 Tiffany put volume heavy and directionally bearish 03/23/20 Tiffany put volume heavy and directionally bearish 03/18/20 Unusual put flow in option market yesterday TAK Takeda Pharmaceutical $18.60 / -0.07 (-0.38%) 03/24/20 Largest borrow rate increases among liquid names PCG PG&E $11.35 / +0.245 (+2.21%) 05/05/20 PG&E call volume above normal and directionally bullish 05/04/20 Early notable gainers among liquid option names on May 4th 05/04/20 Largest borrow rate increases among liquid names 04/23/20 Unusual put flow in option market yesterday NG NovaGold $11.71 / +0.27 (+2.36%) 04/01/20 NovaGold options imply 12.5% move in share price post-earnings LOGM LogMeln $85.29 / +0.23 (+0.27%) 12/20/19 LogMein call volume above normal and directionally bullish 12/18/19 LogMein call volume above normal and directionally bullish KL Kirkland Lake Gold $41.02 / +0.91 (+2.27%) 04/13/20 Kirkland Lake Gold call volume above normal and directionally bullish 02/28/20 Kirkland Lake Gold call volume above normal and directionally bullish 02/11/20 Largest borrow rate increases among liquid names 02/10/20 Largest borrow rate increases among liquid names GLD SPDR Gold Shares $163.95 / +0.96 (+0.59%) 03/05/20 Unusually active option classes on open March 5th 02/25/20 Unusually active option classes on open February 25th 02/19/20 Unusually active option classes on open February 19th 02/10/20 Size putspreads in Gold ETF indicated downside view after recent climb ENDP Endo $3.81 / -0.035 (-0.91%) 03/05/20 Endo call volume above normal and directionally bullish 02/24/20 Endo put volume heavy and directionally bearish 01/14/20 Endo call volume above normal and directionally bullish 12/02/19 Endo call volume above normal and directionally bullish DISCA Discovery $20.48 / -0.07 (-0.34%) 01/23/20 Discovery put volume heavy and directionally bearish 01/15/20 Largest borrow rate increases among liquid names 01/08/20 Largest borrow rate increases among liquid names 11/18/19 Early notable gainers among liquid option names on November 18th CZR Caesars $10.05 / +0.185 (+1.88%) 05/12/20 Caesars call volume above normal and directionally bullish 04/20/20 Unusually active option classes on open April 20th 04/20/20 Notable open interest changes for April 20th 04/16/20 Notable open interest changes for April 16th BHC Bausch Health $15.74 / -0.2 (-1.25%) 05/15/20 Bausch Health call volume above normal and directionally bullish 05/13/20 Bausch Health call volume above normal and directionally bullish 04/28/20 Largest borrow rate increases among liquid names 04/20/20 Largest borrow rate increases among liquid names AEM Agnico Eagle $68.96 / +2.88 (+4.36%) 05/07/20 Agnico Eagle call volume above normal and directionally bullish 04/23/20 Agnico Eagle call volume above normal and directionally bullish 04/06/20 Agnico Eagle call volume above normal and directionally bullish 02/28/20 Largest borrow rate increases among liquid names GLD GLD SPDR Gold Shares $163.95 / +0.96 (+0.59%) 05/15/20 On The Fly: ETF fund flow highlights 05/08/20 On The Fly: ETF fund flow highlights 04/24/20 On The Fly: ETF fund flow highlights 04/17/20 On The Fly: ETF fund flow highlights
Hot Stocks	Endo up 6% after reporting Q1 results 08:25 05/07/20 05/07 08:25 05/07/20 08:25 ENDP Endo $4.20 / +0.04 (+0.96%) ShowHide Related Items >><< Street Research Events ENDP Endo $4.20 / +0.04 (+0.96%) 04/24/20 Fly Intel: Top five analyst initiations 04/24/20 Citi Endo initiated with a Buy at Citi 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim 05/07/20 Endo - ENDP 07/06/20 PDUFA Date for CCH
Hot Stocks	Endo reports Q1 International Pharmaceuticals segment revenue $29M » 08:24 05/07/20 05/07 08:24 05/07/20 08:24 ENDP Endo $4.20 / +0.04 (+0.96%) Q1 International… Q1 International Pharmaceuticals segment revenues of $29 million were comparable to the same period in the prior year. ShowHide Related Items >><< Street Research Events ENDP Endo $4.20 / +0.04 (+0.96%) 04/24/20 Fly Intel: Top five analyst initiations 04/24/20 Citi Endo initiated with a Buy at Citi 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim 05/07/20 Endo - ENDP 07/06/20 PDUFA Date for CCH
Hot Stocks	Endo reports Q1 Generic Pharmaceuticals revenue $251M vs. $219M last year » 08:24 05/07/20 05/07 08:24 05/07/20 08:24 ENDP Endo $4.20 / +0.04 (+0.96%) Q1 Generic… Q1 Generic Pharmaceuticals segment revenues were $251 million, an increase of 15% compared to $219 million in first-quarter 2019. This increase was primarily attributable to recent product launches and accelerated prescription fulfillment resulting from consumer access concerns related to the COVID-19 pandemic and was partially offset by continued competitive pressure on commoditized generic products. During first-quarter 2020, the Generic Pharmaceuticals segment launched four products. ShowHide Related Items >><< Street Research Events ENDP Endo $4.20 / +0.04 (+0.96%) 04/24/20 Fly Intel: Top five analyst initiations 04/24/20 Citi Endo initiated with a Buy at Citi 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim 05/07/20 Endo - ENDP 07/06/20 PDUFA Date for CCH
Hot Stocks	Endo reports Q1 Sterile Injectables segment revenue $336M vs. $270M last year » 08:22 05/07/20 05/07 08:22 05/07/20 08:22 ENDP Endo $4.20 / +0.04 (+0.96%) Q1 Sterile Injectables… Q1 Sterile Injectables segment revenues were $336 million, an increase of 25% compared to $270 million in first-quarter 2019. This increase reflects the strong growth of VASOSTRICT and ADRENALIN resulting primarily from significantly increased sales volume towards the end of the quarter due to higher utilization primarily to treat patients infected with COVID-19, increased channel inventory stocking and price. ShowHide Related Items >><< Street Research Events ENDP Endo $4.20 / +0.04 (+0.96%) 04/24/20 Fly Intel: Top five analyst initiations 04/24/20 Citi Endo initiated with a Buy at Citi 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim 05/07/20 Endo - ENDP 07/06/20 PDUFA Date for CCH

Hot Stocks

Endo reports Q1 Branded Pharmaceuticals segment revenues $204M » 08:21

05/07/20

05/07

08:21

05/07/20

08:21

ENDP

Endo

$4.20 / +0.04 (+0.96%)

Q1 Branded…

Q1 Branded Pharmaceuticals segment revenues of $204 million were comparable to the same period in the prior year. Continued strong growth in the segment's Specialty Products portfolio was offset by ongoing generic competition in the segment's Established Products portfolio. Specialty Products revenues increased 17% to $134 million in first-quarter 2020 compared to $115 million in first-quarter 2019, primarily driven by the strong performance of XIAFLEX. Sales of XIAFLEX increased 30% to $89 million compared to $69 million in first-quarter 2019, which was primarily attributable to demand growth driven by continued commercial execution and investment in promotional activities as well as inventory stocking in the specialty pharmacy and specialty distributor channels.

ShowHide Related Items >><<

Street Research
Events

ENDP Endo

$4.20 / +0.04 (+0.96%)

04/24/20: Fly Intel: Top five analyst initiations

04/24/20 Citi: Endo initiated with a Buy at Citi

01/03/20 Piper Sandler: Endo upgraded to Overweight from Neutral at Piper Jaffray

09/11/19 Guggenheim: Endo assumed with a Neutral at Guggenheim

Earnings

Endo reports Q1 adj. EPS 94c, consensus 54c » 06:07

05/07/20

05/07

06:07

05/07/20

06:07

ENDP

Endo

$4.20 / +0.04 (+0.96%)

Reports Q1 revenue $820M,…

Reports Q1 revenue $820M, consensus $712.85M. "I am proud of the way Endo is responding to the challenges associated with the COVID-19 pandemic. We have taken appropriate steps to protect the health and safety of our nearly 3,200 team members and their families around the globe, to support our communities through monetary and product donations, and to rapidly increase the production and distribution of Endo's critical care products which are administered to patients suffering from COVID-19," said Blaise Coleman, President and CEO at Endo. Mr. Coleman continued, "Our first-quarter 2020 results reflect continued strong underlying performance from our Sterile Injectables segment and the Specialty Products Portfolio of our Branded Pharmaceuticals segment. Our results were significantly augmented by higher patient demand and increased customer inventory purchasing due to the COVID-19 pandemic. Although the future impact on our business from COVID-19 is uncertain, we will continue our commitments to keeping our team members safe, reliably supplying critical medicines to patients in need and investing for long term success."

ShowHide Related Items >><<

Street Research
Events

ENDP Endo

$4.20 / +0.04 (+0.96%)

04/24/20: Fly Intel: Top five analyst initiations

04/24/20 Citi: Endo initiated with a Buy at Citi

01/03/20 Piper Sandler: Endo upgraded to Overweight from Neutral at Piper Jaffray

09/11/19 Guggenheim: Endo assumed with a Neutral at Guggenheim

Over a month ago
Initiation	Fly Intel: Top five analyst initiations » 10:08 04/24/20 04/24 10:08 04/24/20 10:08 RDUS Radius Health $16.89 / -0.34 (-1.97%) , QFIN 360 Finance $7.46 / +0.08 (+1.08%) , AWK American Water $125.39 / +0.46 (+0.37%) , WTRG Essential Utilities $42.97 / +0.34 (+0.80%) , SJW SJW Group $57.74 / -0.05 (-0.09%) , ARW Arrow Electronics $53.98 / +0.24 (+0.45%) , AVT Avnet $27.29 / + (+0.00%) , TEVA Teva $10.22 / +0.05 (+0.49%) , MNK Mallinckrodt $3.47 / +0.015 (+0.43%) , ENDP Endo $4.04 / +0.27 (+7.16%) , BHC Bausch Health $17.41 / +1.09 (+6.68%) Catch up on today's… Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Radius Health (RDUS) initiated with a Hold at Stifel. 2. 360 Finance (QFIN) initiated with an Overweight at Morgan Stanley. 3. American Water (AWK), Essential Utilities (WTRG), and SJW Group (SJW) were initiated with an Outperform at RBC Capital. 4. Arrow Electronics (ARW) was initiated with a Buy at Loop Capital while Avnet (AVT) was initiated with a Hold. 5. Endo (ENDP) and Bausch Health (BHC) were initiated with a Buy at Citi, while Mallinckrodt (MNK) was initiated with a Sell, and Teva (TEVA) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here. ShowHide Related Items >><< Street Research Events RDUS QFIN AWK WTRG SJW ARW AVT TEVA MNK ENDP BHC RDUS Radius Health $16.89 / -0.34 (-1.97%) 04/23/20 Stifel Radius Health initiated with a Hold at Stifel 04/23/20 Stifel Radius Health initiated with a Hold at Stifel 11/06/19 SVB Leerink Radius Health price target lowered to $35 from $49 at SVB Leerink 08/29/19 Citi Radius Health upgraded to Buy from Neutral at Citi QFIN 360 Finance $7.46 / +0.08 (+1.08%) 04/24/20 Morgan Stanley 360 Finance initiated with an Overweight at Morgan Stanley 05/14/19 China Renaissance 360 Finance initiated with a Buy at China Renaissance AWK American Water $125.39 / +0.46 (+0.37%) 04/24/20 RBC Capital American Water initiated with an Outperform at RBC Capital 04/15/20 Goldman Sachs American Water upgraded to Buy from Neutral at Goldman Sachs 02/20/20 Baird American Water price target raised to $139 from $128 at Baird 02/20/20 Wells Fargo American Water price target raised to $147 from $128 at Wells Fargo WTRG Essential Utilities $42.97 / +0.34 (+0.80%) 04/24/20 RBC Capital Essential Utilities initiated with an Outperform at RBC Capital 04/15/20 Goldman Sachs Essential Utilities initiated with a Neutral at Goldman Sachs SJW SJW Group $57.74 / -0.05 (-0.09%) 04/24/20 RBC Capital SJW Group initiated with an Outperform at RBC Capital 11/15/19 JPMorgan SJW Group initiated with a Neutral at JPMorgan 10/07/19 Fly Intel: Top five analyst initiations 10/07/19 Macquarie SJW Corp. initiated with an Outperform rating at Macquarie ARW Arrow Electronics $53.98 / +0.24 (+0.45%) 04/24/20 Loop Capital Arrow Electronics initiated with a Buy at Loop Capital 04/23/20 Loop Capital Arrow Electronics initiated with a Buy at Loop Capital 04/14/20 Raymond James Arrow Electronics downgraded to Market Perform from Outperform at Raymond James 03/20/20 Wells Fargo Wells Fargo cuts price targets in IT Hardware & Communications Networking space AVT Avnet $27.29 / + (+0.00%) 04/24/20 Loop Capital Avnet initiated with a Hold at Loop Capital 04/23/20 Loop Capital Avnet initiated with a Hold at Loop Capital 03/19/20 Wells Fargo Avnet upgraded to Equal Weight from Underweight at Wells Fargo 03/16/20 SunTrust Avnet upgraded to Hold, Belden to Buy at SunTrust TEVA Teva $10.22 / +0.05 (+0.49%) 04/24/20 Citi Teva initiated with a Neutral at Citi 04/06/20 UBS Teva upgraded to Buy from Neutral at UBS 03/23/20 SunTrust SunTrust lowers price targets among Pharmaceuticals due to COVID-19 03/09/20 Oppenheimer Amgen price target lowered to $250 from $256 at Oppenheimer MNK Mallinckrodt $3.47 / +0.015 (+0.43%) 04/24/20 Citi Mallinckrodt initiated with a Sell at Citi 02/25/20 Stifel Mallinckrodt clearing path for shares to be revalued, says Stifel 01/22/20 Wells Fargo Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo 09/10/19 Stifel Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel ENDP Endo $4.04 / +0.27 (+7.16%) 04/24/20 Citi Endo initiated with a Buy at Citi 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim 07/15/19 Fly Intel: Top five analyst downgrades BHC Bausch Health $17.41 / +1.09 (+6.68%) 04/24/20 Citi Bausch Health initiated with a Buy at Citi 04/02/20 Morgan Stanley Bausch Health downgraded to Equal Weight with $17 price target at Morgan Stanley 04/02/20 Morgan Stanley Bausch Health downgraded to Equal Weight from Overweight at Morgan Stanley 03/26/20 Piper Sandler Doctor survey shows 'massive' near-term COVID disruption, says Piper Sandler 04/27/20 Avnet - AVT 04/30/20 Arrow Electronics - ARW 05/05/20 Mallinckrodt - MNK 05/05/20 SJW Group - SJW 05/07/20 Endo - ENDP 05/07/20 Teva - TEVA 05/07/20 Bausch Health - BHC 05/07/20 American Water - AWK 05/07/20 Essential Utilities - WTRG 05/07/20 Radius Health - RDUS 07/06/20 PDUFA Date for CCH 09/12/20 PDUFA Date for Terlipressin 04/29/20 SJW Group 05/06/20 Essential Utilities Inc 05/13/20 Arrow Electronics Inc 05/13/20 American Water Works Company, Inc. 09/14/20 American Water 09/15/20 American Water
Initiation	Endo initiated with a Buy at Citi » 06:25 04/24/20 04/24 06:25 04/24/20 06:25 ENDP Endo $3.77 / +0.39 (+11.54%) Citi analyst Navann Ty… Citi analyst Navann Ty initiated coverage of Endo International with a Buy rating and $7 price target. The low opioid settlements so far and their rationale may help with Endo's future negotiations, Ty tells investors in a research note. The analyst recommends investors buy the stock for the company's progress in cellulite. ShowHide Related Items >><< Street Research Events ENDP Endo $3.77 / +0.39 (+11.54%) 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim 07/15/19 Fly Intel: Top five analyst downgrades 07/15/19 Morgan Stanley Endo, Teva downgraded to Underweight on underappreciated risks at Morgan Stanley 05/07/20 Endo - ENDP 07/06/20 PDUFA Date for CCH
Conference/Events	Cantor Fitzgerald biopharma analyst to hold analyst/industry conference call » 10:55 03/09/20 03/09 10:55 03/09/20 10:55 ENDP Endo $4.00 / -0.6 (-13.04%) , JNJ Johnson & Johnson $138.54 / -3.59 (-2.53%) , MNK Mallinckrodt $2.46 / -0.47 (-16.04%) , TEVA Teva $9.10 / -1.19 (-11.56%) Specialty Pharmaceuticals… Specialty Pharmaceuticals Analyst Chen and Biopharma Analyst Folkes, along with Ilkiko Mehes, Pharmaceutical Industry Legal Advisor, discuss the opioid liabilities for Johnson & Johnson, Teva Pharma, Endo Pharma, Mallinckrodt and others, as well as a review of Purdue's opioid litigation and the potential for a universal settlement at a luncheon discussion being held in Boston on March 9 at 12 pm. ShowHide Related Items >><< Street Research Events ENDP JNJ MNK TEVA ENDP Endo $4.00 / -0.6 (-13.04%) 01/03/20 Piper Sandler Endo upgraded to Overweight from Neutral at Piper Jaffray 09/11/19 Guggenheim Endo assumed with a Neutral at Guggenheim 07/15/19 Fly Intel: Top five analyst downgrades 07/15/19 Morgan Stanley Endo, Teva downgraded to Underweight on underappreciated risks at Morgan Stanley JNJ Johnson & Johnson $138.54 / -3.59 (-2.53%) 03/06/20 Credit Suisse Johnson & Johnson price target lowered to $159 from $170 at Credit Suisse 03/04/20 Citi Johnson & Johnson initiated with a Buy at Citi 03/02/20 Wells Fargo Baxter, J&J best positioned to weather coronavirus spread, says Wells Fargo 01/27/20 Credit Suisse Johnson & Johnson price target raised to $170 from $163 at Credit Suisse MNK Mallinckrodt $2.46 / -0.47 (-16.04%) 02/25/20 Stifel Mallinckrodt clearing path for shares to be revalued, says Stifel 01/22/20 Wells Fargo Revance, Amphastar named top 2020 Specialty Pharmaceuticals ideas at Wells Fargo 09/10/19 Stifel Mallinckrodt's sale of BioVectra helps alleviate cash pressure, says Stifel 09/09/19 Stifel Mallinckrodt price target lowered to $8 from $20 at Stifel TEVA Teva $9.10 / -1.19 (-11.56%) 03/09/20 Oppenheimer Amgen price target lowered to $250 from $256 at Oppenheimer 02/26/20 H.C. Wainwright H.C. Wainwright reiterates $51 price target on Amarin shares post Q4 results 02/25/20 Wells Fargo Emergent BioSolutions price target raised to $75 from $66 at Wells Fargo 02/24/20 Edward Jones Teva downgraded to Sell from Hold at Edward Jones 03/09/20 Biopharma & Specialty Pharmaceuticals--Luncheon 04/06/20 Specialty Pharma/Biopharma--Luncheon 03/12/20 Global Healthcare Conference 2020 03/13/20 AAAAI Annual Meeting 2020 04/14/20 Johnson & Johnson - JNJ 03/17/20 Meeting with Johnson & Johnson 07/06/20 PDUFA Date for CCH

12:24	Loeb's Third Point owns Boeing debt, not equity, CNBC reports»
10:36	Muddy Waters questions eHealth revenue collection in renewed short attack»
10:08	Fly Intel: Top five analyst initiations»
10:08	Fly Intel: Top five analyst downgrades»
10:08	Fly Intel: Top five analyst upgrades»

BHE	Benchmark Electronics - BHE
DBD	Diebold - DBD
MATW	Matthews - MATW
HLIO	Helios Technologies - HLIO
GNK	Genco Shipping - GNK
CNXN	Connection - CNXN
KLIC	Kulicke & Soffa - KLIC
IRDM	Iridium - IRDM
NSIT	Insight Enterprises - NSIT
DXPE	DXP Enterprises - DXPE

SPCE	Block Trade
PLRX	IPO
WMG	IPO
DT	Secondary
NTLA	Secondary
OSUR	Secondary
ARCE	Spot Secondary
EVFM	Spot Secondary
HLNE	Spot Secondary
RNR	Spot Secondary

Get Full Fly Access